Pantel, Klaus

Tumour exosome integrins determine organotropic metastasis

Hoshino, A., Costa-Silva, B., Shen, T.-L., Rodrigues, G., Hashimoto, A., Tesic Mark, M., Molina, H., Kohsaka, S., Di Giannatale, A., Ceder, S., et al. (2015) · Nature

Extracellular vesicles in diseaseCancer Cells and Metastasis

Cited by 5,101

Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy

Alix-Panabières, C., & Pantel, K. (2016) · Cancer Discovery

Cancer Genomics and DiagnosticsPrenatal Screening and Diagnostics

Cited by 1,394

Liquid biopsy and minimal residual disease - latest advances and implications for cure

Pantel, K., & Alix-Panabières, C. (2019) · Nature Reviews Clinical Oncology

Cancer Genomics and DiagnosticsAcute Lymphoblastic Leukemia research

Cited by 1,110

ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: A report from the ESMO Precision Medicine Working Group

Pascual, J., Attard, G., Bidard, F.-C., Curigliano, G., De Mattos-Arruda, L., Diehn, M., Italiano, A., Lindberg, J., Merker, J. D., Montagut, C., et al. (2022) · Annals of Oncology

Cancer Genomics and DiagnosticsBRCA gene mutations in cancer

Cited by 783

Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients

Rack, B., Schindlbeck, C., Jückstock, J., Andergassen, U., Hepp, P., Zwingers, T., Friedl, T. W. P., Lorenz, R., Tesch, H., Fasching, P. A., et al. (2014) · JNCI: Journal of the National Cancer Institute

Breast Cancer Treatment StudiesCancer Cells and Metastasis

Cited by 615

Liquid Biopsies, What We Do Not Know (Yet)

Bardelli, A., & Pantel, K. (2017) · Cancer Cell

Cancer Genomics and DiagnosticsExtracellular vesicles in disease

Cited by 482

Data Normalization Strategies for MicroRNA Quantification

Schwarzenbach, H., da Silva, A. M., Calin, G., & Pantel, K. (2015) · Clinical Chemistry

Molecular Biology Techniques and ApplicationsMicroRNA in disease regulation

Cited by 468

Tumor-Induced Osteoclast miRNA Changes as Regulators and Biomarkers of Osteolytic Bone Metastasis

Ell, B., Mercatali, L., Ibrahim, T., Campbell, N., Schwarzenbach, H., Pantel, K., Amadori, D., & Kang, Y. (2013) · Cancer Cell

Bone Metabolism and DiseasesMicroRNA in disease regulation

Cited by 266

Minimal residual disease as a target for liquid biopsy in patients with solid tumours

Pantel, K., & Alix-Panabières, C. (2025) · Nature Reviews Clinical Oncology

Cancer Genomics and DiagnosticsCancer Immunotherapy and Biomarkers

Cited by 146

Advances in liquid biopsy approaches for early detection and monitoring of cancer

Babayan, A., & Pantel, K. (2018) · Genome Medicine

Cancer Genomics and DiagnosticsAdvanced biosensing and bioanalysis techniques

Cited by 104